Smart Healthcare System — AI Diagnostics, Telemedicine, and Seoul's Digital Hospital Infrastructure

Healthcare at the Scale of a Megacity

Seoul’s 9.6 million residents are served by one of the most hospital-dense metropolitan areas on Earth. The city contains 394 hospitals, 31 of which are tertiary-care facilities affiliated with major university medical schools — Seoul National University Hospital, Yonsei Severance Hospital, Samsung Medical Center, Asan Medical Center, and Korea University Medical Center among the most prominent. South Korea’s national health insurance system, administered by the National Health Insurance Service (NHIS), covers the entire population with a single-payer model that keeps out-of-pocket costs below 35 percent of total health expenditure. This combination of universal coverage, high hospital density, and a digitally literate population creates ideal conditions for deploying smart healthcare technologies at metropolitan scale.

The Seoul Metropolitan Government (SMG) has pursued healthcare digitization along four interlocking tracks since 2020: artificial intelligence for clinical diagnostics, a telemedicine framework accelerated by the COVID-19 pandemic, the national Health Information Exchange (HIE) data platform, and a digital hospital initiative that redesigns care delivery around connected medical devices and real-time data analytics. Collectively, these programs represent an investment exceeding 2.4 trillion KRW from national and municipal budgets, with additional private-sector spending from hospital groups and medical-technology companies that is difficult to aggregate but estimated at twice the public figure.

AI-Powered Clinical Diagnostics

The Ecosystem of Korean Medical AI Companies

South Korea has produced a cluster of medical AI companies whose products have achieved regulatory approval and clinical deployment at a speed that surprises observers more accustomed to the glacial pace of health-technology adoption in Europe or the United States. Three companies dominate the Seoul hospital landscape:

Lunit. Founded in 2013 and listed on the Korea Exchange in 2022, Lunit develops AI algorithms for radiology and oncology. Its flagship product, Lunit INSIGHT CXR, analyzes chest X-rays for 10 abnormal findings including lung nodules, pneumonia consolidation, and pleural effusion. The algorithm achieved a sensitivity of 97.4 percent and specificity of 95.2 percent in a multi-center validation study published in Radiology in 2023, outperforming the average radiologist’s sensitivity of 87 percent on the same dataset. Lunit INSIGHT CXR is deployed at 18 hospitals in Seoul and more than 3,000 medical sites across 50 countries globally.

Vuno. A medical AI company specializing in predictive analytics and image interpretation. Vuno’s DEEPCARS product predicts cardiac arrest risk six hours before onset using real-time vital-sign monitoring data. Deployed in the intensive care units of seven Seoul hospitals, DEEPCARS reduced unexpected cardiac arrest mortality by 18 percent in a 24-month retrospective study at Severance Hospital. Vuno also develops fundus-image analysis for diabetic retinopathy screening, achieving a diagnostic accuracy of 96.1 percent in Korean population validation studies.

JLK Inspection (now JLK Inc.). Develops AI for neuroimaging. Its Atroscan product quantifies brain volume from MRI scans to assist in early detection of Alzheimer’s disease and other neurodegenerative conditions. The algorithm measures hippocampal, cortical, and ventricular volumes with precision comparable to manual segmentation by neuroradiologists, at a processing time of 90 seconds versus 45 minutes for manual analysis. Atroscan is deployed at 12 Seoul hospitals and is used in the national dementia screening program for adults over 65.

Regulatory Pathway and Approval

The Ministry of Food and Drug Safety (MFDS) established a dedicated regulatory track for AI-based medical devices in 2020, classifying them under the existing medical device framework but with adapted review criteria. AI diagnostic tools are classified as Class II or Class III devices depending on clinical risk. Class II devices (screening aids that present findings for physician review) undergo an abbreviated review averaging 120 days. Class III devices (autonomous diagnostic systems that generate clinical decisions without mandatory physician review) require full premarket approval with clinical trial data, averaging 18 months.

As of early 2026, MFDS has approved 248 AI-based medical device products from 94 Korean companies — by far the highest approval count of any national regulator. The U.S. FDA has approved approximately 700 AI/ML-enabled medical devices, but from a much larger applicant pool and over a longer regulatory history. South Korea’s concentrated approval pipeline reflects both MFDS’s streamlined process and the density of medical AI talent in Seoul.

Hospital Deployment Models

Seoul hospitals deploy AI diagnostics in three operational models:

Concurrent reading. The AI analyzes the image simultaneously with the radiologist, and both interpretations are displayed side by side. The radiologist makes the final determination. This model is used at Samsung Medical Center and Asan Medical Center for chest X-ray and mammography screening.

Pre-screening triage. The AI analyzes all incoming studies and flags those with suspected abnormalities, routing them to the top of the radiologist’s worklist. Studies flagged as normal are deprioritized. This model reduces reporting turnaround time for urgent findings by an average of 2.4 hours at Seoul National University Hospital, where Lunit INSIGHT processes approximately 800 chest X-rays per day.

Population screening. The AI operates as the first-pass reader in large-scale screening programs where the volume of studies exceeds radiologist capacity. Korea’s national cancer screening program offers free chest X-rays to all adults over 40 every two years, generating millions of studies annually. AI pre-screening routes only studies with suspected abnormalities to radiologist review, reducing the human review burden by an estimated 65 percent while maintaining detection sensitivity above 96 percent.

Telemedicine Framework

From Emergency Measure to Permanent Infrastructure

South Korea prohibited telemedicine under the Medical Service Act for decades, reflecting the Korea Medical Association’s opposition to remote consultations. The COVID-19 pandemic forced a reversal: on February 24, 2020, the Ministry of Health and Welfare issued an emergency order permitting telephone and video consultations to reduce infection risk at healthcare facilities. Over the next three years, more than 43 million telemedicine consultations were conducted nationwide.

In 2024, the National Assembly passed the Telemedicine Act, making remote consultations a permanent feature of the healthcare system. The law permits video-based consultations for follow-up visits (not initial diagnoses), chronic disease management, and mental health services. It requires that telemedicine platforms meet technical standards set by the Health Insurance Review and Assessment Service (HIRA), including end-to-end encryption, patient identity verification via government-issued credentials (including the DID-based digital identity system), and real-time access to the patient’s medical records through the Health Information Exchange.

Seoul’s Telemedicine Infrastructure

The SMG operates a municipal telemedicine platform — Seoul Health Connect — that integrates with the national telemedicine framework but adds city-specific features. Seoul Health Connect provides:

Chronic disease management. Approximately 1.8 million Seoul residents have been diagnosed with hypertension, diabetes, or both. Seoul Health Connect enrolls these patients in remote monitoring programs where connected blood-pressure monitors and glucometers transmit readings to a cloud platform. AI algorithms analyze trends and flag patients whose readings deviate from target ranges, triggering an automated telemedicine appointment with their primary care physician. In a 12-month evaluation at 28 participating clinics, the program reduced emergency department visits among enrolled diabetic patients by 22 percent and improved average HbA1c levels by 0.4 percentage points.

Mental health services. Seoul’s mental health crisis — South Korea has the highest suicide rate in the OECD at 25.2 per 100,000 in 2023 — drives demand for accessible counseling. Seoul Health Connect partners with the SMG’s 25 district mental health centers to offer video counseling sessions with licensed psychologists and psychiatrists. The platform processes approximately 4,200 mental health consultations per month, with wait times averaging 3.5 days compared to 14 days for in-person appointments at the same centers.

Post-discharge monitoring. Patients discharged from Seoul hospitals after surgery or acute illness can enroll in a 30-day telemedicine follow-up program. Connected devices (pulse oximeters, thermometers, wound cameras) transmit data to the discharging hospital’s care team. A clinical decision-support algorithm flags patients showing signs of surgical-site infection, respiratory deterioration, or medication non-adherence. Early results from a pilot at Asan Medical Center showed a 31 percent reduction in 30-day readmission rates for enrolled patients.

Digital Divide in Telemedicine Access

Telemedicine’s convenience disproportionately benefits younger, digitally fluent populations. The SMG’s own data shows that only 14 percent of Seoul Health Connect users are over 65, despite this demographic accounting for 18 percent of the city’s population and a disproportionate share of chronic disease burden. The digital inclusion programs operated by the SMG include a dedicated telemedicine literacy track that teaches elderly residents how to use video consultations and connected health devices. As of early 2026, 22,000 seniors have completed the telemedicine training module, but the gap between training completion and regular platform use remains wide — only 38 percent of training graduates went on to conduct three or more telemedicine consultations.

Health Information Exchange Data Platform

Architecture and Scope

South Korea’s Health Information Exchange (HIE) is a national platform that enables the electronic sharing of patient medical records across healthcare institutions. Administered by the Health Insurance Review and Assessment Service (HIRA) in partnership with the National Health Insurance Service (NHIS), the HIE connects 67,000 healthcare institutions including hospitals, clinics, pharmacies, and long-term care facilities. It stores more than 52 million patient records — effectively the entire insured population — and processes an average of 4.2 million record-access transactions per day.

The HIE holds several categories of clinical data:

• Prescription and medication history. Every prescription dispensed through the NHIS system is recorded, creating a comprehensive medication history that prevents dangerous drug interactions. When a physician prescribes a new medication, the HIE’s drug-interaction checking algorithm scans the patient’s full medication list and issues alerts for 14 categories of interaction risk.
• Diagnostic records. Laboratory results, imaging reports, and pathology findings from participating institutions are stored in standardized HL7 FHIR format, enabling interoperability across hospitals that use different electronic health record (EHR) systems.
• Procedure history. Surgical records, hospitalization summaries, and outpatient procedure notes provide longitudinal care histories that travel with the patient regardless of which institution they visit.
• Vaccination records. Complete immunization histories, including COVID-19 vaccination series, are maintained and accessible through the HIE.

Data Governance and Privacy

South Korea’s Personal Information Protection Act (PIPA) classifies health data as sensitive personal information requiring enhanced protections. The HIE operates under a consent-based access model: patients must authorize each healthcare institution to access their records, either through a blanket consent at enrollment or through per-visit authorization via the Seoul Digital Wallet’s DID credential. Patients can revoke consent at any time and can view an audit log of every institution that has accessed their records.

De-identified health data is available for research through the NHIS National Sample Cohort, which provides a stratified random sample of 2 percent of the insured population (approximately 1 million records) to approved researchers. Seoul’s Big Data Campus — part of the digital government services infrastructure — hosts a dedicated health-data analysis environment where researchers can query de-identified HIE data without the records ever leaving the secure data enclave.

AI and Big Data Applications

The HIE’s comprehensive dataset has become one of the most valuable resources for medical AI development and public health analytics in Asia.

Disease surveillance. HIRA operates a real-time disease surveillance system that monitors HIE prescription data for anomalous spikes in antiviral, antibiotic, and antipyretic dispensing, providing early-warning signals for infectious disease outbreaks. During the COVID-19 pandemic, this system detected localized outbreaks 3–5 days before traditional epidemiological surveillance based on case reporting.

Treatment effectiveness research. The longitudinal nature of HIE data enables large-scale observational studies comparing treatment outcomes across populations. Korean researchers have published more than 200 peer-reviewed studies using HIE data since 2020, covering topics from statin effectiveness in elderly populations to long-term outcomes of robotic surgery for prostate cancer.

AI model training. Medical AI companies — including Lunit, Vuno, and JLK — access de-identified HIE datasets to train and validate their algorithms. The concentration of clinical data in a single national platform gives Korean medical AI companies a data advantage that fragmented healthcare systems in the United States or Europe cannot easily replicate.

Digital Hospital Initiative

Seoul’s Five Digital Hospital Pioneers

In 2023, the SMG and the Ministry of Health and Welfare jointly designated five Seoul hospitals as “Digital Hospital Innovation Centers,” providing each with a 50-billion-KRW grant to redesign care delivery around digital technologies. The five hospitals are Seoul National University Hospital, Severance Hospital (Yonsei University), Samsung Medical Center, Asan Medical Center, and Seoul National University Bundang Hospital (technically located in Seongnam but serving a large Seoul commuter population).

Each hospital is pursuing a different focus area within the digital hospital framework:

Seoul National University Hospital — AI-integrated clinical workflows. SNUH is embedding AI diagnostic tools into every stage of the clinical workflow, from triage in the emergency department (where an AI system analyzes vital signs and chief complaints to assign acuity levels) to discharge planning (where a predictive model estimates readmission risk and recommends post-discharge monitoring intensity). The hospital processes approximately 8,000 outpatient visits per day, and AI tools now touch some aspect of care delivery for an estimated 60 percent of those visits.

Severance Hospital — Smart operating rooms. Yonsei Severance is piloting smart operating rooms equipped with real-time surgical-navigation systems that overlay preoperative imaging onto the surgeon’s field of view through augmented-reality headsets. The system, developed in partnership with Korean medical-device maker Hutom, also records complete surgical video with AI-generated time-stamped annotations of key surgical steps, creating a searchable surgical database for training and quality assurance. Hutom’s surgical AI has analyzed more than 12,000 surgical videos and can identify 28 distinct procedural steps across five surgical specialties.

Samsung Medical Center — Digital patient experience. SMC is redesigning the patient journey with a smartphone-based platform that handles appointment scheduling, real-time wait-time updates, indoor wayfinding (using Bluetooth beacons at two-meter accuracy throughout the hospital campus), medication reminders, and post-visit surveys. The platform reduced average patient wait times in outpatient clinics by 18 minutes and decreased no-show rates by 7.3 percentage points in its first year of operation.

Asan Medical Center — Connected ICU. AMC’s medical intensive care unit has been rebuilt as a fully connected environment where every bedside device — ventilator, infusion pump, cardiac monitor, arterial line transducer — streams data continuously to a central analytics platform. AI algorithms monitor 127 physiological parameters per patient and generate early-warning scores for sepsis, respiratory failure, and hemodynamic instability. The connected ICU has demonstrated a 23 percent reduction in sepsis mortality compared to the hospital’s conventional ICU, attributable to earlier detection and intervention.

Seoul National University Bundang Hospital — Robotic process automation. SNUBH is applying robotic process automation (RPA) to administrative workflows including insurance claim processing, pathology-report routing, and supply-chain management. RPA bots handle approximately 40 percent of the hospital’s insurance claim submissions, reducing average processing time from 12 minutes to 45 seconds per claim and freeing administrative staff to focus on complex cases requiring human judgment.

Integration With Seoul’s Smart-City Stack

Smart healthcare does not exist in isolation from Seoul’s broader digital infrastructure. Several integration points are already operational or under active development.

S-DoT environmental health correlations. Air-quality data from the S-DoT sensor network is being linked to NHIS health-outcome data to study the relationship between hyperlocal PM2.5 exposure and respiratory disease incidence at the neighborhood level. A joint SMG-NHIS research project launched in 2025 is using S-DoT’s two-minute PM2.5 readings combined with NHIS outpatient visit records to build a predictive model that could trigger public health advisories targeted to specific districts rather than the current city-wide approach.

TOPIS emergency response. When the TOPIS transport system receives a 119 emergency call (Korea’s equivalent of 911), it now accesses the caller’s HIE record — with their pre-registered emergency consent — to provide paramedics with critical medical history (allergies, current medications, chronic conditions) before they arrive on scene. Average ambulance response times in Seoul are 7.2 minutes; having medical context available from dispatch rather than after arrival saves an estimated 3–5 minutes of clinical assessment time at the scene.

5G-enabled remote surgery. SK Telecom’s 5G network provides the low-latency backbone for remote surgical consultations. In 2025, surgeons at Severance Hospital in Seoul guided a robotic surgical procedure at Wonju Severance Hospital, 130 kilometers away, using 5G-connected surgical teleoperation equipment with an end-to-end latency of 11 milliseconds. While fully remote surgery remains experimental, remote surgical mentoring — where an expert surgeon in Seoul provides real-time guidance overlaid on a trainee surgeon’s AR display at a regional hospital — is moving toward routine clinical use.

Digital identity for health access. The DID-based digital identity system serves as the authentication layer for HIE access, Seoul Health Connect, and the digital hospital patient platforms. A single DID credential replaces the separate login credentials that patients previously needed for each hospital’s portal, reducing authentication friction and improving data portability.

Challenges and the Road Ahead

Seoul’s smart healthcare system faces several challenges that will determine whether current pilots become permanent infrastructure.

Physician resistance. The Korea Medical Association initially opposed both telemedicine and AI diagnostics, viewing them as threats to physician autonomy and income. While the Telemedicine Act’s passage represented a legislative defeat for the KMA’s absolutist position, the association continues to lobby for restrictions — particularly a prohibition on AI systems issuing diagnostic conclusions without mandatory physician review. The tension between AI capability and physician gatekeeping will shape how aggressively hospitals deploy autonomous diagnostic tools.

Data fragmentation despite the HIE. While the HIE covers NHIS-insured services, it does not capture data from private health screenings, wellness apps, wearable devices, or care received abroad. For a population that increasingly generates health data outside the formal healthcare system, the HIE’s scope is a limitation. The NHIS is exploring APIs that would allow patients to voluntarily contribute wearable and wellness data to their HIE record, but privacy concerns and technical standardization challenges have slowed progress.

Cybersecurity of health data. Health records are among the most valuable targets for cyberattackers. The NHIS HIE has not suffered a publicly disclosed breach, but the system processes 4.2 million transactions per day across 67,000 connected institutions, presenting an attack surface that requires constant vigilance. The SMG’s cybersecurity infrastructure includes dedicated monitoring of healthcare network traffic, but the interconnection of hospital systems with smart-city platforms — S-DoT, TOPIS, 5G — multiplies the potential entry points.

Equity of access. AI diagnostics and digital hospital features are concentrated in Seoul’s large tertiary hospitals. Community clinics and small hospitals in lower-income districts lack the IT infrastructure and clinical expertise to deploy these technologies. If smart healthcare widens the quality gap between elite and community-level care, it will undermine the equity goals of South Korea’s universal health insurance system. The SMG’s response — channeling some digital hospital grant funding to 45 community health centers across Seoul — is a start, but the resource disparity remains significant.

South Korea’s combination of universal health insurance, a concentrated population of medical AI companies, a national health data platform, and a regulatory environment that moves faster than most OECD peers positions Seoul as one of the most advanced smart healthcare environments in the world. Whether that advantage translates into measurably better population health outcomes — not just impressive technology demonstrations — depends on closing the gaps in access, equity, and integration that the current system still exhibits.